< Back to all clusters
[TECHNOLOGY] · United States · 9 sources

started · updated

Warhound startup raises $200M to develop genetically modified military dogs

Warhound, a new Texas-based defense biotechnology startup, has raised $200 million in seed funding to develop genetically enhanced and cloned working dogs for the U.S. military, law enforcement, and emergency services. Founded by Palmer Luckey of Anduril and Ben Lamm of Colossal Biosciences, the company aims to reduce U.S. reliance on European breeders, as currently over 80% of military working dogs are sourced from Europe.

The company plans to use gene editing and cloning to address common health issues in breeds like Belgian Malinois, German Shepherds, and Labradors, such as hip dysplasia and cancer predisposition. Future research may target enhancements in scent ability, speed, and agility. In addition to biological modifications, the dogs will be equipped with Anduril’s battlefield technologies, including advanced sensors, software, and protective gear like ballistic vests.

The project has faced criticism from animal rights organizations, including PETA and the Animal Legal Defense Fund. Critics argue that genetic engineering for warfare is ethically problematic and that robotic alternatives, such as those developed by Boston Dynamics, are more efficient and humane. Warhound expects its first litter of puppies to be born in early 2027.

Entities

Anduril · Ben Lamm · Colossal Biosciences · Palmer Luckey · Warhound

Claims

What the coverage asserts, and how many sources carry each claim.